Text Messaging for Disease Monitoring in Childhood Nephrotic Syndrome
- PMID: 31440697
- PMCID: PMC6698307
- DOI: 10.1016/j.ekir.2019.04.026
Text Messaging for Disease Monitoring in Childhood Nephrotic Syndrome
Abstract
Introduction: There is limited information on effective disease monitoring for prompt interventions in childhood nephrotic syndrome. We examined the feasibility and effectiveness of a novel text messaging system (SMS) for disease monitoring in a multicenter, prospective study.
Methods: A total of 127 patients <19 years with incident nephrotic syndrome were enrolled in the ongoing Nephrotic Syndrome Study Network between June 2015 and March 2018. Text messages soliciting home urine protein results, symptoms, and medication adherence were sent to a designated caregiver (n = 116) or adolescent patient (n = 3). Participants responded by texting. Feasibility of SMS was assessed by SMS adoption, retention, and engagement, and concordance between participant-reported results and laboratory/clinician assessments. The number of disease relapses and time-to-remission data captured by SMS were compared with data collected by conventional visits.
Results: A total of 119 of 127 (94%) patients agreed to SMS monitoring. Retention rate was 94%, with a median follow-up of 360 days (interquartile range [IQR] 353-362). Overall engagement was high, with a median response rate of 87% (IQR, 68-97). Concordance between SMS-captured home urine protein results and edema status with same-day in-person study visit was excellent (kappa values 0.88 and 0.92, respectively). SMS detected a total of 108 relapse events compared with 41 events captured by scheduled visits. Median time to remission after enrollment was 22 days as captured by SMS versus 50 days as captured by scheduled visits.
Conclusion: SMS was well accepted by caregivers and adolescent patients and reliably captured nephrotic syndrome disease activity between clinic visits. Additional studies are needed to explore the impact of SMS on disease outcomes.
Keywords: caregivers; children; health status; mobile health; nephrotic syndrome; text messaging.
Figures
Similar articles
-
Feasibility of a Novel COVID-19 Telehealth Care Management Program Among Individuals Receiving Treatment for Opioid Use Disorder: Analysis of a Pilot Program.JMIR Form Res. 2022 Aug 30;6(8):e39772. doi: 10.2196/39772. JMIR Form Res. 2022. PMID: 35973033 Free PMC article.
-
A Culturally Adapted SMS Text Messaging Intervention to Promote Antiretroviral Therapy Adherence Among African Americans: Protocol for a Single-Arm Trial.JMIR Res Protoc. 2020 Dec 10;9(12):e21592. doi: 10.2196/21592. JMIR Res Protoc. 2020. PMID: 33300885 Free PMC article.
-
Text Messaging for Exercise Promotion in Older Adults From an Upper-Middle-Income Country: Randomized Controlled Trial.J Med Internet Res. 2016 Jan 7;18(1):e5. doi: 10.2196/jmir.5235. J Med Internet Res. 2016. PMID: 26742999 Free PMC article. Clinical Trial.
-
Mobile phone text messaging to improve medication adherence in secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2017 Apr 29;4(4):CD011851. doi: 10.1002/14651858.CD011851.pub2. Cochrane Database Syst Rev. 2017. PMID: 28455948 Free PMC article. Review.
-
Use of mobile phone text message reminders in health care services: a narrative literature review.J Med Internet Res. 2014 Oct 17;16(10):e222. doi: 10.2196/jmir.3442. J Med Internet Res. 2014. PMID: 25326646 Free PMC article. Review.
Cited by
-
Pediatric contributions and lessons learned from the NEPTUNE cohort study.Pediatr Nephrol. 2024 Jan 18. doi: 10.1007/s00467-023-06256-7. Online ahead of print. Pediatr Nephrol. 2024. PMID: 38233720 Review.
-
Differences in Multicomponent Pharmacokinetics, Tissue Distribution, and Excretion of Tripterygium Glycosides Tablets in Normal and Adriamycin-Induced Nephrotic Syndrome Rat Models and Correlations With Efficacy and Hepatotoxicity.Front Pharmacol. 2022 Jun 9;13:910923. doi: 10.3389/fphar.2022.910923. eCollection 2022. Front Pharmacol. 2022. PMID: 35754482 Free PMC article.
-
Integrated Metabolomics and Network Pharmacology to Establish the Action Mechanism of Qingrekasen Granule for Treating Nephrotic Syndrome.Front Pharmacol. 2021 Dec 6;12:765563. doi: 10.3389/fphar.2021.765563. eCollection 2021. Front Pharmacol. 2021. PMID: 34938183 Free PMC article.
-
A dual efficacy-implementation trial of a novel mobile application for childhood nephrotic syndrome management: the UrApp for childhood nephrotic syndrome management pilot study protocol (UrApp pilot study).BMC Nephrol. 2020 Apr 9;21(1):125. doi: 10.1186/s12882-020-01778-w. BMC Nephrol. 2020. PMID: 32272901 Free PMC article.
-
Using Existing Mobile Technology to Monitor Disease Activity: An Example in Childhood Nephrotic Syndrome.Kidney Int Rep. 2019 Jun 18;4(8):1037-1039. doi: 10.1016/j.ekir.2019.06.006. eCollection 2019 Aug. Kidney Int Rep. 2019. PMID: 31440693 Free PMC article. No abstract available.
References
-
- Eddy A.A., Symons J.M. Nephrotic syndrome in childhood. Lancet. 2003;362:629–639. - PubMed
-
- Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int. 1981;20:765–771. - PubMed
-
- The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr. 1981;98:561–564. - PubMed
-
- Greenbaum L.A., Benndorf R., Smoyer W.E. Childhood nephrotic syndrome—current and future therapies. Nat Rev Nephrol. 2012;8:445–458. - PubMed
-
- Lombel R.M., Hodson E.M., Gipson D.S. Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol. 2013;28:409–414. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
